ロード中...
β(3)-Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer
The role of the vitronectin receptor (α(v)β(3)-integrin) as a tumor promoter seems well established, and, consequently, therapies that block this integrin are currently in clinical testing. We undertook the current study to determine whether α(v)β(3)-integrin is an appropriate target in ovarian canc...
保存先:
| 主要な著者: | , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Investigative Pathology
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2774080/ https://ncbi.nlm.nih.gov/pubmed/19808644 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/ajpath.2009.090028 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|